Congenital Nonspherocytic Hemolytic Anemia
- 1 September 1961
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 102 (3), 313-320
- https://doi.org/10.1001/archpedi.1961.02080010315006
Abstract
It has been well demonstrated in man and in other species that the fundamental expression of a hereditary chemical disorder may be the deletion of a single metabolic or enzymic step. The extent to which such loss in enzymic activity is due to dimimished amounts or to a qualitative inefficiency of the enzyme has been a matter of considable interest. The latter possibility has appeared particularly tenable since the outstanding demonstrations by Pauling, Itano, et al1 and by Ingram and Hunt2,3 of the qualitative changes in sickle hemoglobin. Erythrocytic glucose-6-phosphate dehydrogenase (G-6-PD) has been studied in 2 varieties4,5 of a hereditary defect of this enzyme, primaquine-sensitive hemolytic anemia,6-9 and recently10 a certain type of congenital nonspherocytic hemolytic anemia. Although the active G-6-PD in primaquinesensitive erythrocytes from Negro males is qualitatively similar, if not identical, to that from normal persons, the G-6-PD of a Caucasian maleKeywords
This publication has 6 references indexed in Scilit:
- DIFFERENT ENZYMIC EXPRESSIONS OF MUTANTS OF HUMAN GLUCOSE-6-PHOSPHATE DEHYDROGENASEProceedings of the National Academy of Sciences, 1960
- An Hereditary Enzymatic Defect in Erythrocyte Metabolism: Glucose-6-Phosphate Dehydrogenase Deficiency1Journal of Clinical Investigation, 1958
- Abnormal human haemoglobinsBiochimica et Biophysica Acta, 1958
- Abnormal human haemoglobinsBiochimica et Biophysica Acta, 1958
- Further studies on the properties and assay of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of rat liverBiochemical Journal, 1953
- Symposium on Clinical HemoglobinometryAmerican Journal of Clinical Pathology, 1953